Jacobs Ian Seth 4
4 · Augmedix, Inc. · Filed Oct 7, 2020
Insider Transaction Report
Form 4
Augmedix, Inc.NONE
Jacobs Ian Seth
DirectorPresident, Secretary CEO & CFO
Transactions
- Other
Common stock, par value $0.0001 per share
2020-10-05−90,000→ 160,000 total
Footnotes (1)
- [F1]Pursuant to the terms of an Agreement and Plan of Merger and Reorganization, dated as of October 5, 2020, by and among the Issuer, August Acquisition Corp. ("Acquisition Sub"), and Augmedix Operating Company (f/k/a Augmedix, Inc.) ("Augmedix"), on October 5, 2020, Acquisition Sub merged with and into Augmedix, with Augmedix continuing as the surviving entity (the "Merger") and as the Issuer's wholly-owned subsidiary. As a condition to the Merger, pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and canceled 90,000 shares of the Issuer's common stock prior to the consummation of the Merger. The reporting person resigned as a director and officer of the Issuer upon consummation of the Merger